Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders

被引:13
|
作者
Kubota, Takeo [1 ]
Takae, Hirasawa [1 ]
Miyake, Kunio [1 ]
机构
[1] Univ Yamanashi, Dept Epigenet Med, Chuo Ku, 1110 Shimokato, Kofu, Yamanashi 4903898, Japan
关键词
epigenetics; DNA methylation; histone modification; environmental factor; neurodevelopmental disease; reversible; drug; therapy;
D O I
10.3390/ph5040369
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The number of children with mild neurodevelopmental disorders, such as autism, has been recently increasing in advanced countries. This increase is probably caused by environmental factors rather than genetic factors, because it is unlikely that genetic mutation rates suddenly increased within a short period. Epigenetics is a mechanism that regulates gene expression, depending not on the underlying DNA sequence but on the chemical modifications of DNA and histone proteins. Because mental stress can alter the epigenetic status in neuronal cells, environmental factors may alter brain function through epigenetic changes. However, one advantage of epigenetic changes is their reversibility. Therefore, diseases due to abnormal epigenetic regulation are theoretically treatable. In fact, several drugs for treating mental diseases are known to have restoring effects on aberrant epigenetic statuses, and a novel therapeutic strategy targeting gene has been developed. In this review, we discuss epigenetic mechanisms of congenital and acquired neurodevelopmental disorders, drugs with epigenetic effects, novel therapeutic strategies for epigenetic diseases, and future perspectives in epigenetic medicine.
引用
收藏
页码:369 / 383
页数:15
相关论文
共 50 条
  • [21] EPIGENETIC MECHANISMS IN DEVELOPMENTAL DISORDERS
    Carey, N.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2015, 59 (09) : 801 - 801
  • [22] Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives
    Deidda, Gabriele
    Bozarth, Ignacio F.
    Cancedda, Laura
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8
  • [23] Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders
    Wulff, Andreas B.
    Nichols, Charles D.
    Thompson, Scott M.
    NEUROPHARMACOLOGY, 2023, 231
  • [24] Therapeutic Advances in Autism and Other Neurodevelopmental Disorders
    Jeffrey L. Neul
    Mustafa Sahin
    Neurotherapeutics, 2015, 12 : 519 - 520
  • [25] Clinical trials for neurodevelopmental disorders: At a therapeutic frontier
    Jeste, Shafali S.
    Geschwind, Daniel H.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (321)
  • [26] Postnatal therapeutic approaches in genetic neurodevelopmental disorders
    Levy, Gilad
    Barak, Boaz
    NEURAL REGENERATION RESEARCH, 2021, 16 (03) : 414 - 422
  • [27] Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders
    Crider, Amanda
    Pillai, Anilkumar
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 360 (01): : 48 - 58
  • [28] Therapeutic Advances in Autism and Other Neurodevelopmental Disorders
    Neul, Jeffrey L.
    Sahin, Mustafa
    NEUROTHERAPEUTICS, 2015, 12 (03) : 519 - 520
  • [29] Postnatal therapeutic approaches in genetic neurodevelopmental disorders
    Gilad Levy
    Boaz Barak
    Neural Regeneration Research, 2021, 16 (03) : 414 - 422
  • [30] The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
    Braat, Sien
    Kooy, R. Frank
    NEURON, 2015, 86 (05) : 1119 - 1130